In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

GSK received approval from U.K.'s medicines regulatory body to bring its blood-cancer blockbuster candidate Blenrep back to the market, enabling the British pharma giant to expand its oncology ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

The U.S. CDC's Advisory Committee recommends the use of GSK's pentavalent Penmenvy vaccine as part of the adolescent ...

Their appointment was initiated by the outgoing board of directors. The four new members will bring many years of experience in the biotech and ...

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today ...

The pharmaceutical company said Thursday that the U.S. Advisory Committee on Immunization Practices had issued a positive recommendation on GSK's 5-in-1 meningitis vaccine Penmenvy as well as its ...

The Onychomycosis Treatment Market in Europe has witnessed substantial growth in recent years, with a valuation of Onychomycosis Treatment Market. Projections suggest a steady upward trajectory, ...

The Global Onychomycosis Treatment Market is poised for substantial growth in the coming decade, with projections indicating a significant expansion. This report provides a comprehensive analysis of ...

The Global Prescription Drugs Market is valued at USD 1240.33 Billion in 2024 and is projected to reach a value of USD 2755 ...

The appendix is thought to play a role in all of this by producing inflammatory proteins that trigger the body to produce ...